The FDA's formally published list will be the authoritative source when released
In order of the number of reports (Table 4), the most common adverse events for liraglutide were nausea, hyperglycemia, vomiting, diarrhea, pancreatitis, decreased appetite, weight loss, headache, upper abdominal pain, and constipation
Context-dependent functional differences among AREs fit with findings from another group that combined high-throughput promoter-dependent drug screens and transcriptomics analyses to uncover that low doses of the chemotherapeutic doxorubicin downregulate cell cycle genes while high doses upregulate DNA damage response genes
While these fluctuations are generally mild, they can be concerning for individuals with pre-existing cardiovascular conditions
Stampfer, S